Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
NSPR Transcript
InspireMD, Inc. (NSPR) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Neutral5-13
InspireMD, Inc. (NSPR) Q1 2026 Earnings Call Transcript
Unknown5-4
The earnings call lacked crucial financial and strategic information, and the emphasis on risks and uncertainties suggests potential negative outcomes. The absence of discussions on revenue, margins, and cash flow, combined with concerns about regulatory and market risks, indicates a lack of positive catalysts. This lack of transparency and guidance is likely to result in a strong negative stock price reaction.
InspireMD, Inc. (NSPR) Q4 2025 Earnings Call Transcript
Unknown3-18
The earnings call presents mixed signals. Financial performance was strong with revenue, gross margin, and net income all showing significant improvements. However, the lack of specific guidance and vague responses in the Q&A section, particularly regarding new market expansions and supply chain challenges, introduce uncertainty. The absence of strategic initiatives and return plans further limits positive sentiment. Given these factors, the stock price is likely to remain stable, leading to a neutral prediction.
InspireMD, Inc. (NSPR) Q3 2025 Earnings Call Transcript
Positive11-4
The company reported strong financial metrics with 39% YoY revenue growth and improved gross margins. Despite a net loss, the cash position is strong due to recent financing. The U.S. launch of CGuard Prime shows positive momentum with strong physician feedback. The Q&A highlighted positive sentiment and growth expectations, although management avoided specific margin guidance. Overall, the earnings call suggests a positive short-term outlook, with expected growth in the U.S. market and improved margins.
NSPR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
